Dosing Algorithm

  • Dosing Algorithm

Detailed App Info:

  • Last Changed:Time:
  • Current Version:Version: 3.0.1
  • Device Type:Device: iPhone Ready
  • Category:Category: Medical
  • iTunes Seller:Seller:
  • Download Size:App Size: 12.91 MB

Application Description

Twitter:
Google:
Facebook:
The VICTRELIS® (boceprevir) Dosing Algorithm application is for US health care professionals only. This Dosing Algorithm, from Merck, is designed to allow US health care professionals to determine the recommended length of therapy with VICTRELIS.

Privacy Policy:
The VICTRELIS® (boceprevir) Dosing Algorithm may be used without entering any information that directly identifies patients. Information that you record in the “Profile” feature is stored on your Apple device [iPhone®, iPod touch®, iPad®]. If you choose to record the full name or other information that directly identifies a patient, we recommend that you use the Profile Password Protection feature or Device Lock feature which is available under the Settings feature to protect personal information. Merck does not collect personal information when you use this application. For more information about our privacy practices, please see our privacy commitment at http://www.merck.com/policy/commitment/home.html, as well as the application License Agreement/Terms and Conditions.

iPhone, iPod touch, and iPad are registered trademarks of Apple Inc.

Please Note:
To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 1-800-444-2080.
AINF-1003366-0014 09/12

Requirements

Your mobile device must have at least 12.91 MB of space to download and install Dosing Algorithm app. Dosing Algorithm was updated to a new version. Purchase this version for $0.00

If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of Merck & Co Inc at http://www.merckmobileapps.com/home-page-2.html#Victrelis-Dose-Apple.

Copyright Copyright © 2012 Merck & Co., Inc. All rights reserved.